Roadmap

2025 Q1-Q2

• Launch AI drug screening testnet, integrating cancer target databases.

• Initiate the first "Citizen Scientist" recruitment program to attract global participants.

• Complete the optimization of the platform's infrastructure and full deployment of blockchain technology.

2025 Q3-Q4

• Complete the first decentralized clinical trial (Goal: ALS treatment optimization).

• Launch the medical data NFT trading market, starting data transactions and assetization.

• Establish strategic collaborations with multiple multinational medical institutions to expand ecosystem coverage.

2026 Q1-Q2

• Achieve full decentralization of DAO governance, with community-led decision-making.

• Platform’s drug development cost-saving target exceeds $1 billion.

• Further expand the global medical data sharing network to enhance data liquidity.

2026 Q3-Q4

• Promote the application of AI and blockchain technology in medical devices.

• Accelerate cross-industry collaborations, driving deep integration between AI and the healthcare industry.

• Enhance automation and data security of platform smart contracts.

2027+

• BioAI becomes a global standard setter for decentralized healthcare.

• Drive the intelligent transformation of global healthcare infrastructure, achieving a more efficient service system.

• Establish a global medical collaboration network, facilitating multinational medical data sharing and research cooperation.